Larvol Delta - Bicara-Therapeutics-Announces-Publication-of-an-Abstract-with-Preliminary-Phase-1b-Expansion-Cohort-Data-Evaluating-750mg-of-Ficerafusp-Alfa-Weekly-Plus-Pembrolizumab-in-1L-HPVnegative-RM-HNSCC-at-ESMO-Asia-2025

ficerafusp alfa (BCA101) - Biocon

https://www.globenewswire.com/news-release/2025/12/01/3196851/0/en/Bicara-Therapeutics-Announces-Publication-of-an-Abstract-with-Preliminary-Phase-1b-Expansion-Cohort-Data-Evaluating-750mg-of-Ficerafusp-Alfa-Weekly-Plus-Pembrolizumab-in-1L-HPV-neg.html

Dec 1, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next